adialpharma

-1

archive,paged,author,author-adialpharma,author-2,paged-6,author-paged-6,bridge-core-2.5.8,ajax_fade,page_not_loaded,,qode-theme-ver-24.3,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

Author: adialpharma

Posted at 29 Nov, 14:41h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Establishes Scientific Advisory Board and Appoints Global Thought Leader in the Field of Alcohol Use Disorder

Posted at 16 Nov, 15:32h in News & Media by adialpharma 0 Comments

0 Likes

EHealth Radio invited Adial’s CEO, William Stilley, for an interview. Listen to the interview to learn more!

Posted at 13 Nov, 14:49h in Press Release by adialpharma 0 Comments

0 Likes

Addiction Drug Developer Adial Pharmaceuticals Receives Notice of Allowance of Canadian Patent for AD04 in Alcohol Use Disorder

Posted at 02 Nov, 14:02h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals to Present at Dawson James Securities 4th Annual Small Cap Growth Conference

Posted at 26 Sep, 15:12h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals to Present at The MicroCap Conference on October 1st in New York City

Posted at 18 Sep, 15:13h in Press Release by adialpharma 0 Comments

0 Likes

Addiction Drug Developer Adial Pharmaceuticals Successfully Passes Patent Opposition Period in Europe for AD04 in Alcohol Use Disorder; Reports No Challenges to European Patent

Posted at 12 Sep, 15:14h in Press Release by adialpharma 0 Comments

0 Likes

Alcohol Use Disorder Drug Candidate from Adial Pharmaceuticals Shows Positive Stability Results

Posted at 04 Sep, 15:14h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell this Morning at 9:30 AM Eastern

04 Aug ADial Pharmaceuticals Promotes Joseph Truluck to Chief Operating and Chief Financial Officer

Posted at 14:29h in News & Media by adialpharma 0 Comments

0 Likes

CHARLOTTESVILLE, VA, April XX, 2017 -- ADial Pharmaceuticals LLC (“ADial”), a developer of pharmaceutical products focused on novel and effective treatments for addictions and related disorders, announced the promotion of Joseph Truluck from Vice President of Operations and Finance to Chief Operating and Chief Financial...

Posted at 03 Aug, 14:00h in News & Media by adialpharma 0 Comments

0 Likes

Woodcock: We need better biomarkers